Pharmacokinetics and tolerance of a new penem antibiotic, FCE 22101, in healthy volunteers after a single intravenous dose
Authors:
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 36 (6) , 633-635
Abstract
The clinical tolerance and pharmacokinetics of FCE 22101 (sodium (5R, 6S)-6-[(1R)-hydroxyethyl]-2-carbamoyloxymethyl-2-penem-3-carboxylate), a new penem antibiotic, have been studied after giving a single i.v. dose of 4 mg·kg−1 to ten healthy male volunteers. The pharmacokinetics was estimated according to a two-compartment open model. The peak plasma concentration (Cmax) was 15.5 (1.08) µg·ml−1, mean (SEM). FCE 22101 was rapidly cleared from the systemic circulation [ \(t_{1/2\lambda _z } \) =44.2 (4.2) min; CL=7.21 (0.47) ml·kg−1·min−1]. The mean apparent volume of distribution at steady-state was 246 (16.9) ml·kg−1. The mean residence time relative to the 10 min infusion was 39.4 (1.5)min. Urinary recovery of FCE 22101 showed wide inter-subject variation, ranging from 10.2 to 53.6% of the dose. No subject complained of adverse effects.
Keywords
This publication has 9 references indexed in Scilit:
- Pharmacokinetics and clinical tolerability of FCE 22101, a new penem antibiotic, in healthy volunteers after a single i.m. administration.1989
- Pharmacokinetics and metabolism of FCE 22101, a new penem antibiotic.1989
- Structure determination of the primary renal metabolite of the penem fce 22101.The Journal of Antibiotics, 1988
- Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1983
- Urinary Recovery of N -Formimidoyl Thienamycin (MK0787) as Affected by Coadministration of N -Formimidoyl Thienamycin Dehydropeptidase InhibitorsAntimicrobial Agents and Chemotherapy, 1983
- Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humansAntimicrobial Agents and Chemotherapy, 1983
- Pharmacokinetics of imipenem in healthy volunteersJournal of Antimicrobial Chemotherapy, 1983
- Synthesis and biological properties of sodium (5R,6S,8R)-6.ALPHA.-hydroxyethyl-2-carbamoyloxymethyl-2-penem-3-carboxylate (FCE 22101) and its orally absorbed esters FCE 22553 and FCE 22891.The Journal of Antibiotics, 1983
- Effects of Change in Elimination on Various Parameters of the Two-Compartment Open ModelJournal of Pharmaceutical Sciences, 1972